Xiidra

Bausch + Lomb seeks funding for eye drug acquisition from Novartis
BioPharma Dive
Wed, 09/13/23 - 11:32 am
Bausch + Lomb
Novartis
M&A
Xiidra
Bausch + Lomb to acquire Xiidra, ‘front of eye’ assets from Novartis
Healio
Fri, 06/30/23 - 10:10 am
Bausch + Lomb
M&A
Novartis
Xiidra
dry eye disease
Most-clicked pharma news for week ending March 18 2023: Medtronic offers early retirement package, Novartis to sell ophthalmological assets, and Pfizer tops list of drugs with price increases
CP WIre
Sat, 03/18/23 - 03:37 pm
Medtronic
Medtech
inflation
drug pricing
Pfizer
Novartis
Merck
Bristol Myers Squibb
Keytruda
Opdivo
Yervoy
lung cancer
Xiidra
JNJ
executive compensation
Most-clicked pharma news for week ending March 18 2023: Medtronic offers early retirement package, Novartis to sell ophthalmological assets, and Pfizer tops list of drugs with price increases
Sat, 03/18/23 - 03:35 pm
Medtronic
Medtech
inflation
drug pricing
Pfizer
Novartis
Merck
Bristol Myers Squibb
Keytruda
Opdivo
Yervoy
lung cancer
Xiidra
JNJ
executive compensation
After $3.4B deal and EU withdrawal, Novartis looks to sell Xiidra
Fierce Pharma
Tue, 03/14/23 - 11:30 am
Novartis
Xiidra
ophthalmology
Two biotechs target dry eye disease after Novartis’ Xiidra problems
Pharmaforum
Thu, 03/4/21 - 09:57 am
dry eye disease
Novartis
Xiidra
Sylentis
Azura Ophthalmics
Novartis introduces inflammatory villain in its first Xiidra dry eye DTC campaign
Fierce Pharma
Thu, 07/23/20 - 10:51 am
Novartis
Xiidra
DTC advertising
dry eye disease
Takeda takes a $200M hit after Novartis is forced to yank its marketing application for Xiidra
Endpoints
Mon, 06/29/20 - 10:26 am
Takeda
Novartis
Xiidra
Europe
EMA
dry eye disease
Novartis strikes out with dry eye med Xiidra in Europe
Seeking Alpha
Fri, 06/26/20 - 09:52 am
Novartis
dry eye disease
Europe
Xiidra
CHMP
Small biotech Oyster Point sets up pitch to disrupt dry eye market with nasal spray
Endpoints
Mon, 05/11/20 - 10:36 am
Oyster Point Pharma
dry eye disease
OC-01
Allergan
Restasis
Shire
Xiidra
Novartis wraps up acquisition of Takeda’s dry eye drug Xiidra
Pharmaceutical Business Review
Tue, 07/2/19 - 10:24 am
Novartis
Takeda
Xiidra
hdry eye disease
Takeda sells Shire’s Xiidra, transfers 400 staffers to Novartis in $3.4B deal
Fierce Pharma
Thu, 05/9/19 - 11:11 am
Takeda
Shire
Novartis
M&A
Xiidra
dry eye disease
Takeda Is Said to Weigh Sale of Shire Eye Drug to Cut Debt
Bloomberg
Thu, 09/13/18 - 12:08 pm
Takeda
Shire
M&A
Xiidra
Hoping to shake Allergan/Shire’s dry eye dominance, Oyster Point posts positive Phase IIb data for rival drug
Endpoints
Thu, 07/12/18 - 11:49 am
Oyster Point
OC-02
dry eye disease
Allergan
Restasis
Shire
Xiidra
Ocugen’s Dry Eye Disease Therapy Could Compete with Allergan and Shire
Xtalks
Wed, 03/21/18 - 10:55 am
Ocugen
dry eye disease
OCU310
Shire
Allergan
Restasis
Xiidra
Shire's DTC move to scrap smiling patients for double 'i's pays off—and it thinks other pharmas should take note
Fierce Pharma
Thu, 04/13/17 - 09:39 am
Shire
DTC ads
patients
Xiidra
dry eye disease
Allergan Is Losing Its No. 2 Product More Rapidly Than Expected
Seeking Alpha
Wed, 12/21/16 - 10:53 am
Allergan
dry eye disease
Restasis
Shire
Xiidra
Allergan's Restasis Faces Dry Eye Threat: Examining XIIDRA's Initial Sales Trends
Seeking Alpha
Tue, 11/8/16 - 10:09 am
Allergan
dry eye disease
Restasis
Xiidra
Shire
Shire wants consumers and their eyes to be 'Friends'
BioPharma Dive
Thu, 10/13/16 - 10:40 am
Shire
celebrity endorsements
dry eye disease
Xiidra
Shire taps Jennifer Aniston for awareness campaign as it enters the eye care market
Medical Marketing and Media
Fri, 08/26/16 - 10:02 am
Shire
dry eye disease
Xiidra
celebrity endorsements

Pages